Drug Discovery Featured Articles & Applications

  1. Does TSLP Inhibition Signal The Next Wave Of Respiratory Biologics? 4/1/2026

    Thymic stromal lymphopoietin (TSLP) inhibition has firmly established itself as a strategy in respiratory disease. This article highlights some promising drug candidates and next-generation approaches.

  2. The Missing Data Set In Drug Discovery: Patient Experience As Decision Data 3/30/2026

    Drug discovery has become highly effective at capturing molecular detail, yet the experience of disease remains difficult to incorporate into early scientific decisions.

  3. Research Center Layout Helps Lower Barriers To Cross-Industry Collaboration 3/27/2026

    Discover how one research center, uniquely built for collaboration, enables the collection and analysis of high-quality specimens and data that will fuel both current and future research collaborations.

  4. What If The U.S. Government Stopped Funding Biotech? 3/23/2026

    It sets off a real tension – ideological, economic, even personal. But what would happen if the U.S. government cut direct financial support for “biotechnology research,” leaving it entirely to investors, private and public markets, and bigger pharma? "Our industry’s mind-meld says with no government largesse our biotech industry collapses," writes Chief Editor Louis Garguilo. It's an "outlandish hypothetical," but he asks for a few minutes to go through this. And he has help in making his case.

  5. What's Next For ADCs: How Combinations Will Help Define The Future Of Treatment 3/23/2026

    Insights gained from advancing ADC combination therapies in lung cancer are now shaping innovative approaches across multiple tumor types.

  6. 5 Takeaways From The Boston Open Science & Innovation Forum 3/20/2026

    The recent Boston Open Science & Innovation Forum was co-hosted by the Open Molecular Software Foundation (OMSF) and Ginkgo Datapoints.

  7. From "Live Drug" To Precision Tool: Redefining CAR T Safety 3/20/2026

    Through important chemistry and the right engineering, there’s new opportunity for CAR T therapeutics to target different forms of cancer with limited toxicity.

  8. NAMs In France And Europe: The Current Landscape 3/20/2026

    The EU is establishing a credible and scalable NAM ecosystem, but challenges still need to be overcome before life sciences professionals and patients can reap the benefits.

  9. Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery 3/19/2026

    We caught up with Melissa Murray, Ph.D., and Amy Rommel, Ph.D., to discuss tau-associated neurodegenerative diseases.

  10. Proteomics Biomarkers Beyond Blood 3/16/2026

    Effective biomarker strategies have the potential to accelerate decision-making, de-risk development, and help drive precision medicine.